{"meshTagsMajor":["Point Mutation"],"meshTags":["Humans","Adult","Male","Proto-Oncogene Proteins B-raf","Aged, 80 and over","Female","Prevalence","Hutchinson\u0027s Melanotic Freckle","Middle Aged","Point Mutation","Skin Neoplasms","Melanoma","Aged"],"meshMinor":["Humans","Adult","Male","Proto-Oncogene Proteins B-raf","Aged, 80 and over","Female","Prevalence","Hutchinson\u0027s Melanotic Freckle","Middle Aged","Skin Neoplasms","Melanoma","Aged"],"genes":["BRAF V600K","BRAF V600E"],"publicationTypes":["Letter","Research Support, Non-U.S. Gov\u0027t"],"title":"The BRAF V600K mutation is more frequent than the BRAF V600E mutation in melanoma in situ of lentigo maligna type.","pubmedId":"24026210"}